Calcineurin inhibitor free immunosuppression with everolimus and MMF in maintenance therapy of long term heart transplant recipients

被引:0
|
作者
Vollenbroeker, Beate [1 ]
Stypmann, Joerg [2 ]
Langer, Claus [3 ]
Schmid, Christof [3 ]
Suwelack, Barbara [1 ]
机构
[1] Univ Hosp Muenster, Dept Internal Med, Munster, Germany
[2] Univ Hosp Muenster, Dept Cardiol & Angiol, Munster, Germany
[3] Univ Hosp Muenster, Inst Clin Chem & Lab Med, Munster, Germany
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
引用
收藏
页码:203 / 203
页数:1
相关论文
共 50 条
  • [1] Calcineurin inhibitor-free immunosuppression using everolimus (Certican) in maintenance heart transplant recipients: 6 Months' follow-up
    Rothenburger, Markus
    Teerling, Elisa
    Bruch, Christian
    Lehmkuhl, Hans
    Suwelack, Barbara
    Bara, Christoph
    Wichter, Thomas
    Hinder, Frank
    Schmid, Christof
    Stypmann, Joerg
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2007, 26 (03): : 250 - 257
  • [2] Prospective Study of Everolimus With Calcineurin Inhibitor-Free Immunosuppression in Maintenance Heart Transplant Patients: Results at 2 Years
    Engelen, Markus A.
    Amler, Susanne
    Welp, Henryk
    Vahlhaus, Christian
    Gunia, Stefan
    Sindermann, Juergen R.
    Rothenburger, Markus
    Stypmann, Joerg
    [J]. TRANSPLANTATION, 2011, 91 (10) : 1159 - 1165
  • [3] EVEROLIMUS AS THE ONLY COMPONENT OF LONG-TERM MAINTENANCE IMMUNOSUPPRESSION AT LIVER TRANSPLANT RECIPIENTS
    Salienko, Anastasia
    Syutkin, Vladimir E.
    Novruzbekov, Murad
    [J]. HEPATOLOGY, 2021, 74 : 877A - 878A
  • [4] CLINICAL OUTCOME IN HEART TRANSPLANT RECIPIENTS (HTX) RECEIVING EVEROLIMUS IN COMBINATION WITH THE CALCINEURIN INHIBITOR TACROLIMUS OR CYCLOSPORIN A IN COMPARISON WITH A CALCINEURIN INHIBITOR FREE IMMUNOSUPPRESSIVE THERAPY
    Fuchs, U.
    Zittermann, A.
    Meschede, E.
    Ensminger, S.
    Schulz, U.
    Gummert, J.
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 : 31 - 31
  • [5] CALCINEURIN INHIBITOR WITHDRAWAL IN THE PRESENCE OF EVEROLIMUS IS FEASIBLE IN MAINTENANCE LIVER TRANSPLANT RECIPIENTS
    Fischer, Lutz
    De Simone, Paolo
    Nevens, Frederik
    Metselaat, Herold J.
    Dumortier, Jerome
    Duvoux, Christophe
    Boudjema, Karim
    Le Treut, Yves Patrice
    Sterneck, Martina R.
    [J]. HEPATOLOGY, 2008, 48 (04) : 566A - 566A
  • [6] EVEROLIMUS-BASED IMMUNOSUPPRESSION TO REVERSE CALCINEURIN-INHIBITOR-ASSOCIATED MYOPATHIC SYMPTOMS IN HEART TRANSPLANT RECIPIENTS
    Meyer, S.
    Deuse, T.
    Baholli, L.
    Sattinger, E.
    Schlueter, M.
    von Stritzky, A.
    Reichenspurner, H.
    Costard-Jaeckle, A.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 46 - 47
  • [7] Calcineurin-Inhibitor Free Sirolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients
    Rossano, Joseph W.
    Ryan, Rachel M.
    Orfanelli, Laura
    McCandless, Karen V.
    Kaufman, Beth D.
    Lin, Kimberly Y.
    Paridon, Stephen M.
    Hanna, Brian D.
    Shaddy, Robert E.
    [J]. CIRCULATION, 2012, 126 (21)
  • [8] CONVERSION FROM CALCINEURIN INHIBITOR-BASED TO EVEROLIMUS-BASED IMMUNOSUPPRESSION IN LIVER TRANSPLANT RECIPIENTS: LONG-TERM OUTCOME
    Dayangac, Murat
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 363 - 363
  • [9] Everolimus Based Immunosuppression Strategies in Adult Lung Transplant Recipients: Calcineurin Inhibitor Minimization Versus Calcineurin Inhibitor Elimination
    Ivulich, Steven
    Paul, Eldho
    Kirkpatrick, Carl
    Dooley, Michael
    Snell, Greg
    [J]. TRANSPLANT INTERNATIONAL, 2023, 36
  • [10] Calcineurin Inhibitor Free Immunosuppression in Heart Transplant Recipients Is Associated with Preserved Renal Function and Good Survival: Long Term Follow-Up
    Barbero, C.
    Fitzsimons, S.
    Lewis, C.
    Parameshwar, J.
    Pettit, S. J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S301 - S302